Global Transdermal Skin Patch Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Transdermal Skin Patch market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Transdermal Skin Patch include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transdermal Skin Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Skin Patch.

The Transdermal Skin Patch market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Skin Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Transdermal Skin Patch Segment by Company

Actavis
Changzhou Siyao
Henan Lingrui Pharmaceutical
Hisamitsu Pharmaceutical
Luye Pharma Group Ltd.
Mundipharma
Purdue Pharma L.P.
Rfl Pharmaceutical
Teikoku Pharma
Mylan
Novartis
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.

Transdermal Skin Patch Segment by Type

Buprenorphine Transdermal Skin Patch
Fentanyl Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Nicotine Transdermal Skin Patch

Transdermal Skin Patch Segment by Application

Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others

Transdermal Skin Patch Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Transdermal Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Transdermal Skin Patch Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Transdermal Skin Patch Sales Estimates and Forecasts (2020-2031)
1.3 Transdermal Skin Patch Market by Type
1.3.1 Buprenorphine Transdermal Skin Patch
1.3.2 Fentanyl Transdermal Skin Patch
1.3.3 Clonidine Transdermal Skin Patch
1.3.4 Nicotine Transdermal Skin Patch
1.4 Global Transdermal Skin Patch Market Size by Type
1.4.1 Global Transdermal Skin Patch Market Size Overview by Type (2020-2031)
1.4.2 Global Transdermal Skin Patch Historic Market Size Review by Type (2020-2025)
1.4.3 Global Transdermal Skin Patch Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Transdermal Skin Patch Sales Breakdown by Type (2020-2025)
1.5.2 Europe Transdermal Skin Patch Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Transdermal Skin Patch Sales Breakdown by Type (2020-2025)
1.5.4 South America Transdermal Skin Patch Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Transdermal Skin Patch Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Transdermal Skin Patch Industry Trends
2.2 Transdermal Skin Patch Industry Drivers
2.3 Transdermal Skin Patch Industry Opportunities and Challenges
2.4 Transdermal Skin Patch Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Transdermal Skin Patch Revenue (2020-2025)
3.2 Global Top Players by Transdermal Skin Patch Sales (2020-2025)
3.3 Global Top Players by Transdermal Skin Patch Price (2020-2025)
3.4 Global Transdermal Skin Patch Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Transdermal Skin Patch Major Company Production Sites & Headquarters
3.6 Global Transdermal Skin Patch Company, Product Type & Application
3.7 Global Transdermal Skin Patch Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Transdermal Skin Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Transdermal Skin Patch Players Market Share by Revenue in 2024
3.8.3 2023 Transdermal Skin Patch Tier 1, Tier 2, and Tier 3
4 Transdermal Skin Patch Regional Status and Outlook
4.1 Global Transdermal Skin Patch Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Transdermal Skin Patch Historic Market Size by Region
4.2.1 Global Transdermal Skin Patch Sales in Volume by Region (2020-2025)
4.2.2 Global Transdermal Skin Patch Sales in Value by Region (2020-2025)
4.2.3 Global Transdermal Skin Patch Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Transdermal Skin Patch Forecasted Market Size by Region
4.3.1 Global Transdermal Skin Patch Sales in Volume by Region (2026-2031)
4.3.2 Global Transdermal Skin Patch Sales in Value by Region (2026-2031)
4.3.3 Global Transdermal Skin Patch Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Transdermal Skin Patch by Application
5.1 Transdermal Skin Patch Market by Application
5.1.1 Relieve Severe Pain
5.1.2 Stop Smoking Cigarettes
5.1.3 Treat an Overactive Bladder
5.1.4 Others
5.2 Global Transdermal Skin Patch Market Size by Application
5.2.1 Global Transdermal Skin Patch Market Size Overview by Application (2020-2031)
5.2.2 Global Transdermal Skin Patch Historic Market Size Review by Application (2020-2025)
5.2.3 Global Transdermal Skin Patch Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Transdermal Skin Patch Sales Breakdown by Application (2020-2025)
5.3.2 Europe Transdermal Skin Patch Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Transdermal Skin Patch Sales Breakdown by Application (2020-2025)
5.3.4 South America Transdermal Skin Patch Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Transdermal Skin Patch Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Actavis
6.1.1 Actavis Comapny Information
6.1.2 Actavis Business Overview
6.1.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Actavis Transdermal Skin Patch Product Portfolio
6.1.5 Actavis Recent Developments
6.2 Changzhou Siyao
6.2.1 Changzhou Siyao Comapny Information
6.2.2 Changzhou Siyao Business Overview
6.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
6.2.5 Changzhou Siyao Recent Developments
6.3 Henan Lingrui Pharmaceutical
6.3.1 Henan Lingrui Pharmaceutical Comapny Information
6.3.2 Henan Lingrui Pharmaceutical Business Overview
6.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
6.3.5 Henan Lingrui Pharmaceutical Recent Developments
6.4 Hisamitsu Pharmaceutical
6.4.1 Hisamitsu Pharmaceutical Comapny Information
6.4.2 Hisamitsu Pharmaceutical Business Overview
6.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
6.4.5 Hisamitsu Pharmaceutical Recent Developments
6.5 Luye Pharma Group Ltd.
6.5.1 Luye Pharma Group Ltd. Comapny Information
6.5.2 Luye Pharma Group Ltd. Business Overview
6.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
6.5.5 Luye Pharma Group Ltd. Recent Developments
6.6 Mundipharma
6.6.1 Mundipharma Comapny Information
6.6.2 Mundipharma Business Overview
6.6.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
6.6.5 Mundipharma Recent Developments
6.7 Purdue Pharma L.P.
6.7.1 Purdue Pharma L.P. Comapny Information
6.7.2 Purdue Pharma L.P. Business Overview
6.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
6.7.5 Purdue Pharma L.P. Recent Developments
6.8 Rfl Pharmaceutical
6.8.1 Rfl Pharmaceutical Comapny Information
6.8.2 Rfl Pharmaceutical Business Overview
6.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
6.8.5 Rfl Pharmaceutical Recent Developments
6.9 Teikoku Pharma
6.9.1 Teikoku Pharma Comapny Information
6.9.2 Teikoku Pharma Business Overview
6.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
6.9.5 Teikoku Pharma Recent Developments
6.10 Mylan
6.10.1 Mylan Comapny Information
6.10.2 Mylan Business Overview
6.10.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mylan Transdermal Skin Patch Product Portfolio
6.10.5 Mylan Recent Developments
6.11 Novartis
6.11.1 Novartis Comapny Information
6.11.2 Novartis Business Overview
6.11.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis Transdermal Skin Patch Product Portfolio
6.11.5 Novartis Recent Developments
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Comapny Information
6.12.2 Johnson & Johnson Business Overview
6.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
6.12.5 Johnson & Johnson Recent Developments
6.13 Teva Pharmaceutical Industries Ltd.
6.13.1 Teva Pharmaceutical Industries Ltd. Comapny Information
6.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
6.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
6.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7 North America by Country
7.1 North America Transdermal Skin Patch Sales by Country
7.1.1 North America Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Transdermal Skin Patch Sales by Country (2020-2025)
7.1.3 North America Transdermal Skin Patch Sales Forecast by Country (2026-2031)
7.2 North America Transdermal Skin Patch Market Size by Country
7.2.1 North America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Transdermal Skin Patch Market Size by Country (2020-2025)
7.2.3 North America Transdermal Skin Patch Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Transdermal Skin Patch Sales by Country
8.1.1 Europe Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Transdermal Skin Patch Sales by Country (2020-2025)
8.1.3 Europe Transdermal Skin Patch Sales Forecast by Country (2026-2031)
8.2 Europe Transdermal Skin Patch Market Size by Country
8.2.1 Europe Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Transdermal Skin Patch Market Size by Country (2020-2025)
8.2.3 Europe Transdermal Skin Patch Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Transdermal Skin Patch Sales by Country
9.1.1 Asia-Pacific Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Transdermal Skin Patch Sales by Country (2020-2025)
9.1.3 Asia-Pacific Transdermal Skin Patch Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Transdermal Skin Patch Market Size by Country
9.2.1 Asia-Pacific Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Transdermal Skin Patch Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Transdermal Skin Patch Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Transdermal Skin Patch Sales by Country
10.1.1 South America Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Transdermal Skin Patch Sales by Country (2020-2025)
10.1.3 South America Transdermal Skin Patch Sales Forecast by Country (2026-2031)
10.2 South America Transdermal Skin Patch Market Size by Country
10.2.1 South America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Transdermal Skin Patch Market Size by Country (2020-2025)
10.2.3 South America Transdermal Skin Patch Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Transdermal Skin Patch Sales by Country
11.1.1 Middle East and Africa Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Transdermal Skin Patch Sales by Country (2020-2025)
11.1.3 Middle East and Africa Transdermal Skin Patch Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Transdermal Skin Patch Market Size by Country
11.2.1 Middle East and Africa Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Transdermal Skin Patch Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Transdermal Skin Patch Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Transdermal Skin Patch Value Chain Analysis
12.1.1 Transdermal Skin Patch Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Transdermal Skin Patch Production Mode & Process
12.2 Transdermal Skin Patch Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Transdermal Skin Patch Distributors
12.2.3 Transdermal Skin Patch Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings